Effects of resveratrol in patients with type 2 diabetes mellitus on skeletal muscle SIRT1 expression and energy expenditure

International Journal of Sport Nutrition and Exercise Metabolism

Volumn 24, Issue 1, 2014, Pages 2-13

  Goh, Kian Peng ^a   Lee, Hwei Yee ^b   Lau, Dawn Pingxi ^a   Supaat, Wilma ^b   Chan, Yiong Huak ^c   Koh, Angela Fang Yung ^a  

^a KHOO TECK PUAT HOSPITAL   (Singapore)

^b TAN TOCK SENG HOSPITAL   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

AMPK; GLUT4; PGC1

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; ANTIBIOTIC AGENT; GLUCOSE TRANSPORTER 4; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; RESVERATROL; SIRTUIN 1; PLANT EXTRACT; PPARGC1A PROTEIN, HUMAN; SIRT1 PROTEIN, HUMAN; SLC2A4 PROTEIN, HUMAN; STILBENE DERIVATIVE; TRANSCRIPTION FACTOR;

ABDOMINAL FAT; ACCELEROMETRY; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBIOTIC THERAPY; ARTICLE; BODY WEIGHT; CALORIMETRY; CELLULITIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC PATIENT; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; ENERGY EXPENDITURE; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPOGLYCEMIA; INSULIN SENSITIVITY; MALE; METABOLIC EQUIVALENT; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE SCANNER; OUTCOME ASSESSMENT; PARALLEL DESIGN; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RESTING METABOLIC RATE; SKELETAL MUSCLE; BASAL METABOLIC RATE; CHEMISTRY; DRUG EFFECTS; ENERGY METABOLISM; EXERCISE; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; REST; VITIS;

AMP-ACTIVATED PROTEIN KINASES; BASAL METABOLISM; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; ENERGY METABOLISM; EXERCISE; GLUCOSE TRANSPORTER TYPE 4; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PHYSICAL EXERTION; PLANT EXTRACTS; REST; SIRTUIN 1; STILBENES; TRANSCRIPTION FACTORS; VITIS;

EID: 84899550705     PISSN: 1526484X     EISSN: 15432742     Source Type: Journal    
DOI: 10.1123/ijsnem.2013-0045     Document Type: Article

References (31)

1. Baur, J.A., Pearson, K.J., Price, N.L., Jamieson, H.A., Lerin, C., Kalra, A., . . . Sinclair, D.A. (2006). Resveratrol improves health and survival of mice on a high-calorie diet. Nature, 444(7117), 337-342. PubMed doi:10.1038/nature05354
2. Baur, J.A., & Sinclair, D.A. (2006). Therapeutic potential of resveratrol: The in vivo evidence. Nature Reviews. Drug Discovery, 5(6), 493-506. PubMed doi:10.1038/nrd2060
3. Bostrom, P., Wu, J., Jedrychowski, M. P., Korde, A., Ye, L., Lo, J. C., . . . Spiegelman, B. M. (2012). A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature, 481(7382), 463-468.
4. Brackenridge, A. L., Jackson, N., Jefferson, W., Stolinski, M., Shojaee-Moradie, F., Hovorka, R., . . . Russell-Jones, D. (2009). Effects of rosiglitazone and pioglitazone on lipoprotein metabolism in patients with Type 2 diabetes and normal lipids. Diabetic Medicine: A Journal of the British Diabetic Association, 26(5), 532-539.
5. Brasnyó, P., Molnár, G.A., Mohás, M., Markó, L., Laczy, B., Cseh, J., . . . Wittmann, I. (2011). Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the akt pathway in Type 2 diabetic patients. The British Journal of Nutrition, 106 (3), 383-389. PubMed doi:10.1017/S0007114511000316
6. Copeland, J.L., & Esliger, D.W. (2009). Accelerometer assessment of physical activity in active, healthy older adults. Journal of Aging and Physical Activity, 17(1), 17-30. PubMed
7. Crouter, S.E., & Bassett, D.R., Jr. (2008). A new 2-regression model for the actical accelerometer. British Journal of Sports Medicine, 42(3), 217-224. PubMed doi:10.1136/bjsm.2006.033399
8. de Kreutzenberg, S.V., Ceolotto, G., Papparella, I., Bortoluzzi, A., Semplicini, A., Dalla Man, C., . . . Avogaro, A. (2010). Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: Potential biochemical mechanisms. Diabetes, 59(4), 1006-1015. PubMed doi:10.2337/db09-1187
9. Diabetes Trials Unit, University of Oxford, UK. (2004). HOMA2 calculator version 2.2.2. Retrieved from http://www.dtu.ox.ac.uk/homacalculator/index.php
10. Dietrichson, P., Coakley, J., Smith, P.E., Griffiths, R.D., Helliwell, T.R., & Edwards, R.H. (1987). Conchotome and needle percutaneous biopsy of skeletal muscle. Journal of Neurology, Neurosurgery, and Psychiatry, 50 (11), 1461-1467. PubMed doi:10.1136/jnnp.50.11.1461
11. Duffield, R., Dawson, B., Pinnington, H. C., & Wong, P. (2004). Accuracy and reliability of a cosmed K4b2 portable gas analysis system. Journal of Science and Medicine in Sport / Sports Medicine Australia, 7(1), 11-22.
12. Elia, M., & Livesey, G. (1992). Energy expenditure and fuel selection in biological systems: The theory and practice of calculations based on indirect calorimetry and tracer methods. World Review of Nutrition and Dietetics, 70, 68-131. PubMed
13. Fujii, N., Jessen, N., & Goodyear, L.J. (2006). AMP-activated protein kinase and the regulation of glucose transport. American Journal of Physiology. Endocrinology and Metabolism, 291(5), E867-E877. PubMed doi:10.1152/ajpendo. 00207.2006
14. Garvey, W.T., Maianu, L., Hancock, J.A., Golichowski, A.M., & Baron, A. (1992). Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM. Diabetes, 41(4), 465-475. PubMed doi:10.2337/diab.41.4.465
15. Gurd, B.J., Perry, C.G., Heigenhauser, G.J., Spriet, L.L., & Bonen, A. (2010). High-intensity interval training increases SIRT1 activity in human skeletal muscle. Applied Physiology, Nutrition, and Metabolism, 35 (3), 350-357.
16. Hardie, D.G., Hawley, S.A., & Scott, J.W. (2006). AMP-activated protein kinase-development of the energy sensor concept. The Journal of Physiology, 574 (Pt 1), 7-15. PubMed doi:10.1113/jphysiol.2006.108944
17. Holmer, H., Pozarek, G., Wirfalt, E., Popovic, V., Ekman, B., Bjork, J., & Erfurth, E.M. (2010). Reduced energy expenditure and impaired feeding-related signals but not high energy intake reinforces hypothalamic obesity in adults with childhood onset craniopharyngioma. The Journal of Clinical Endocrinology and Metabolism,. PubMed
18. Jäger, S., Handschin, C., St-Pierre, J., & Spiegelman, B.M. (2007). AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proceedings of the National Academy of Sciences of the United States of America, 104(29), 12017-12022. PubMed doi:10.1073/pnas.0705070104
19. Kraniou, G. N., Cameron-Smith, D., & Hargreaves, M. (2006). Acute exercise and GLUT4 expression in human skeletal muscle: Influence of exercise intensity. Journal of Applied Physiology (Bethesda, Md.: 1985), 101(3), 934-937.
20. Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., . . . Auwerx, J. (2006). Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell, 127(6), 1109-1122. PubMed doi:10.1016/j.cell.2006.11.013
21. Lenth, R. (2007). Java applets for power and sample size. Retrieved June 6, 2012, from http://homepage.stat.uiowa.edu/~rlenth/Power.
22. Levine, J.A. (2004). Nonexercise activity thermogenesis (NEAT): Environment and biology. American Journal of Physiology. Endocrinology and Metabolism, 286(5), E675-E685. PubMed doi:10.1152/ajpendo.00562.2003
23. Mogensen, M., Sahlin, K., Fernstrom, M., Glintborg, D., Vind, B.F., Beck-Nielsen, H., & Hojlund, K. (2007). Mitochondrial respiration is decreased in skeletal muscle of patients with Type 2 diabetes. Diabetes, 56(6), 1592-1599. PubMed doi:10.2337/db06-0981
24. Park, S. J., Ahmad, F., Philp, A., Baar, K., Williams, T., Luo, H., . . . Chung, J. H. (2012). Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell, 148(3), 421-433.
25. Rasband, W. S. (1997-2011). ImageJ. U. S. National Institutes of Health, Bethesda, USA,
26. Spangenburg, E.E., & Booth, F.W. (2003). Molecular regulation of individual skeletal muscle fibre types. Acta Physiologica Scandinavica, 178(4), 413-424. PubMed doi:10.1046/j.1365-201X.2003.01158.x
27. Sriwijitkamol, A., Coletta, D.K., Wajcberg, E., Balbontin, G.B., Reyna, S.M., Barrientes, J., . . . Musi, N. (2007). Effect of acute exercise on AMPK signaling in skeletal muscle of subjects with Type 2 diabetes: A time-course and dose-response study. Diabetes, 56(3), 836-848. PubMed doi:10.2337/db06-1119
28. Timmers, S., Konings, E., Bilet, L., Houtkooper, R.H., van de Weijer, T., Goossens, G.H., . . . Schrauwen, P. (2011). Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metabolism, 14(5), 612-622. PubMed doi:10.1016/j.cmet.2011.10.002
29. Troiano, R.P., Berrigan, D., Dodd, K.W., Masse, L.C., Tilert, T., & McDowell, M. (2008). Physical activity in the united states measured by accelerometer. Medicine and Science in Sports and Exercise, 40(1), 181-188. PubMed doi:10.1249/mss.0b013e31815a51b3
30. van Wijk, J.P., de Koning, E.J., Martens, E.P., & Rabelink, T.J. (2003). Thiazolidinediones and blood lipids in Type 2 diabetes. Arteriosclerosis, Thrombosis, and Vascular Biology, 23(10), 1744-1749. PubMed doi:10.1161/01.ATV.0000090521.25968.4D
31. Yashiro, T., Nanmoku, M., Shimizu, M., Inoue, J., & Sato, R. (2012). Resveratrol increases the expression and activity of the low density lipoprotein receptor in hepatocytes by the proteolytic activation of the sterol regulatory element-binding proteins. Atherosclerosis, 220 (2), 369-374. PubMed doi:10.1016/j.atherosclerosis.2011.11.006